Development and validation of a risk gene-signature for prediction of recurrence-free survival in clear cell renal cell carcinoma: a retrospective, cohort study
Paper No: 534
| Oncology - Renal Tumours
Yuanlei Chen
3-Minute Oral Presentation 5 | Oncology (Renal) 1
08 Aug 2019 |
10:30:00-11:30:00